Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

Presentation TCT 2025

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

Presenter: Dawood Shehzad

October 28, 2025

Presentation TCT 2025

The Future of Interatrial Shunting

Presenter: Josep Rodés-Cabau

October 27, 2025

Presentation TCT 2025

Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs. HFpEF Presented

Presenter: JoAnn Lindenfeld

October 27, 2025

Presentation TCT 2025

RELIEVE-HF Study Design and Results

Presenter: Gregg W. Stone

October 27, 2025

Presentation TCT 2025

Unmet Needs in HFrEF: The Clinical Opportunity

Presenter: Stefan Verheye

October 27, 2025

Presentation TCT 2025

TCT 538: Real-World Outcomes Following Cardiac Contractility Modulation in HFrEF: A Single-Center Retrospective Experience

Presenter: Kareem Elgendi

October 27, 2025

Presentation TCT 2025

TCT 534: Circulatory Assist Devices in HFrEF: Assessing 30-Day Major Adverse Cardiovascular Events and Clinical Outcomes

Presenter: Mohamed Elhussain

October 27, 2025

Presentation TCT 2025

TCT 558: Low Filling Pressures in Patients with Acute Exacerbation of Heart Failure with Reduced Ejection Fraction (HFrEF) as Identified with a Novel Sensor: A Sub-Analysis of the SEISMIC-HF I Study

Presenter: Anjan Tibrewala

October 26, 2025

Presentation TCT 2025

TCT 1411: HFrEF: A Long-Term Journey Marked by One Narrow Escape After Another

Presenter: Sunanto Ng

October 26, 2025

Presentation TCT 2025

TCT 1777: Refractory HFrEF Salvaged by Atrial Flow Regulator

Presenter: Mega Febrianora

October 25, 2025

News Daily News

HF Risks Stick Around Even When Ejection Fraction Improves

Todd Neale

August 01, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

Presentation NY Valves 2025

Case Resolution

Presenter: Ilan Richter

June 26, 2025

Presentation NY Valves 2025

From the Base of the Papillary Muscles: V-SLING

Presenter: Horst Sievert

June 26, 2025

Presentation NY Valves 2025

Using an Epicardial Approach: CARILLON Updates

Presenter: Samir R. Kapadia

June 26, 2025

Presentation NY Valves 2025

From Inside the LV: ANCORA Updates

Presenter: Ulrich P. Jorde

June 26, 2025

Presentation NY Valves 2025

Case Presentation: 65 year old Woman with Symptomatic HFrEF Refractory to Optimal GDMT

Presenter: Ilan Richter

June 26, 2025

Presentation NY Valves 2025

Is LV Reconstruction a Viable Therapy to Treat the Dilated Heart?

Presenter: Michael I. Brener

June 26, 2025

News Conference News ESC Heart Failure 2025

TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

Todd Neale

May 21, 2025

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

Advertisement

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

The Future of Interatrial Shunting

Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs. HFpEF Presented

RELIEVE-HF Study Design and Results

Unmet Needs in HFrEF: The Clinical Opportunity

TCT 538: Real-World Outcomes Following Cardiac Contractility Modulation in HFrEF: A Single-Center Retrospective Experience

TCT 534: Circulatory Assist Devices in HFrEF: Assessing 30-Day Major Adverse Cardiovascular Events and Clinical Outcomes

TCT 558: Low Filling Pressures in Patients with Acute Exacerbation of Heart Failure with Reduced Ejection Fraction (HFrEF) as Identified with a Novel Sensor: A Sub-Analysis of the SEISMIC-HF I Study

TCT 1411: HFrEF: A Long-Term Journey Marked by One Narrow Escape After Another

TCT 1777: Refractory HFrEF Salvaged by Atrial Flow Regulator

HF Risks Stick Around Even When Ejection Fraction Improves

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Case Resolution

From the Base of the Papillary Muscles: V-SLING

Using an Epicardial Approach: CARILLON Updates

From Inside the LV: ANCORA Updates

Case Presentation: 65 year old Woman with Symptomatic HFrEF Refractory to Optimal GDMT

Is LV Reconstruction a Viable Therapy to Treat the Dilated Heart?

TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content